You searched for united kingdom

Biotech deals partnerships and MA tracker

2024 biotech deals tracker: the latest partnerships and M&A

Explore the pulse of biotech deals on our dedicated page, featuring only the most notable news sorted by top pharmaceutical companies and by month. We meticulously curate and categorize the latest collaborations and M&A activities, ensuring you stay informed about the most significant trends and strategic moves shaping the industry. Would you like to receive […]

March 7, 2024 - 1 minutemin - By Aurore Michelin

2024 biotech funding tracker: recent highlights

Discover the latest in biotech funding on our dedicated page. We meticulously curate and categorize significant fundraising events to keep you informed about the cutting-edge trends and investments driving the industry forward. Explore our tracker organized chronologically and by funding method, providing a comprehensive perspective on the ever-evolving world of biotech fundraising. Would you like […]

February 23, 2024 - 1 minutemin - By Aurore Michelin

Best in Biotech 3 Jan 2024

The top-performing countries in biotechnology (according to the OECD)

Explore the OECD’s top-performing countries for biotech, from the U.S. powerhouse to the promising landscapes of the U.K., Belgium, and more.

January 3, 2024 - 14 minutesmins - By Jules Adam

health innovation startups UK, PHTA Ltd, multi-disciplinary collaboration

Nurturing healthcare innovation: a multi-disciplinary ecosystem to overcome startup challenges

The Covid-19 pandemic highlighted the importance of innovation in the healthcare space when tackling a public health challenge. Nonetheless, health innovation startups today face multiple hurdles, from sourcing funding, to obtaining access to the right expertise, and more. Of late, an additional hurdle that young life science businesses also have to contend with is the […]

March 14, 2023 - 6 minutesmins - By Sudha Sundaram

News and Trends 6 Jan 2023

BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies

BioNTech SE has signed a memorandum of understanding (MoU) with the Government of the United Kingdom. The deal is set to benefit patients by speeding up clinical trials for personalized mRNA immunotherapies. The aim is to provide personalized cancer therapies for up to 10,000 patients by the end of 2030, either through clinical trials or […]

January 6, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 18 Nov 2022

Novavax’ COVID-19 vaccine gets expanded authorization for booster in adults

Novavax, Inc., a U.S-based biotechnology company announced today (November 18) that Health Canada has granted expanded authorization for Covid-19 vaccine Nuvaxovid. The vaccine NVX-CoV2373 for active immunization to prevent the disease caused by severe acute respiratory syndrome (SARS-CoV-2) as a homologous booster in adults aged 18 and older. “Canadians now have access to our […]

November 18, 2022 - 2 minutesmins - By Liza Laws

lupus autoimmune disease neutrophil citryll

News and Trends 22 Jul 2022

Positive news for Aurinia’s voclosporin drug Lupkynis to treat lupus nephritis

British Columbia-based Aurinia Pharmaceuticals Inc. announced today (July 22) that its voclosporin drug has been recommended for marketing authorization to treat adults with active lupus nephritis (LN). The Canadian biopharma company said it is committed to delivering therapeutics that change the course of autoimmune disease after the Committee for Medicinal Products for Human Use (CHMP) […]

July 22, 2022 - 3 minutesmins - By Liza Laws

News and Trends 14 Sep 2020

The Funding Flow Between European and US Life Sciences

Funding is the lifeline of innovative ventures. In an increasingly uncertain environment, looking at the records of past investments can be essential for making sense of the future and getting closer to discovering what’s next for the life sciences industry. Exploring the differences between the two major groups of life sciences investors and the funding […]

September 14, 2020 - 11 minutesmins - By External Contributor

News and Trends 8 May 2019

Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood

Scientists at the University of Cambridge have developed a way to screen treatments for schizophrenia on single cells from a patient’s blood sample, which could speed up drug discovery and help to personalize treatments for people with the condition. Around 21 million people worldwide suffer from schizophrenia, and this is likely to get worse with […]

May 8, 2019 - 2 minutesmins - By Jonathan Smith

study biotechnology best universities Europe

Best in Biotech 15 Apr 2019

The Best Universities to Study Biotechnology in Europe

Choosing the right university and program to study biotechnology can seem an insurmountable task, especially given the growing number of universities that offer courses in this booming field of study. We did some digging around to find a range of biotechnology programs with different specializations in some of the best universities in Europe. Each country […]

April 15, 2019 - 14 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Mar 2019

Second Patient Achieves HIV Remission After Bone Marrow Transplant to Treat Cancer

For the second time in history, an HIV-positive patient with blood cancer has achieved HIV remission following a customized bone marrow transplant to treat their cancer from an HIV-resistant donor. The HIV-positive patient received a bone marrow transplant to treat the blood cancer Hodgkin’s lymphoma, from which he also suffered. The researchers used this cancer […]

March 6, 2019 - 3 minutesmins - By Jonathan Smith

Interview 20 Jun 2018

“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech

Some careers take on an international scope and span the breadth of big players in the pharmaceutical industry and small biotech startups. David Ebsworth, Chairman at Verona Pharma, can count his professional journey among these and gave us the inside scoop on the successes and challenges he faced, his perspective on European biotech, and advice to […]

June 20, 2018 - 9 minutesmins - By Alexander Burik

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us